News & Publications
Stanford Medicine News: Cancer
With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumors, according to researchers at Stanford.
Analyzing individual cancer cells has enabled Stanford researchers to identify the small population of cells that spur relapse in some children with leukemia.
Stanford scientists created an odd couple: a modified version of an immune-signaling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects.
Priming the immune system with induced pluripotent stem cells prevented or slowed the development of cancer in mice, Stanford researchers found.
A quarterly publication for patients and friends of the Stanford Cancer Institute.
A publication with timely information for the cancer researchers, physicians and staff who make up the membership of the Stanford Cancer Institute.
MD Community Newsletter
This quarterly publication is designed to inform our colleagues in the medical community, and especially physicians who are considering treatment options for their patients with cancer, about current clinical trials and research studies available at the NCI-designated Stanford Cancer Institute.
A publication for our community physicians, Stanford Access offers you a look into the programs and faculty of Stanford Health Care. Learn about the latest diagnostics, treatment solutions and innovative procedures happening at Stanford.